MLAB - Mesa Laboratories: Green Shoots Emerge
2025-04-03 15:51:56 ET
Summary
- Mesa Laboratories, Inc. shares are down 60% from 2021 highs but show long-term value with improved operating momentum and reduced leverage.
- The company operates in the highly regulated life science tools markets, with revenues having nearly five-folded over the past decade.
- After sluggish sales and margin trends, the business has seen improved operating momentum as of late.
- MLAB shares trade at 20 times earnings, with potential for re-rating if fourth-quarter performance confirms recent positive trends.
Shares of Mesa Laboratories, Inc. ( MLAB ) offer an interesting case. The company is a great long-term value creator, yet shares are down 60% from 2021 highs and basically have been trading stagnant over the past decade. Amidst continued revenue growth and now some improved margins as well, earnings multiples have compressed quite a bit, to the point at which appeal is rapidly improving....
Mesa Laboratories: Green Shoots Emerge